ECOXIB 60 MR 10'S

About

ECOXIB 60 MR 10'S contains Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). This medication is specifically designed to reduce pain and inflammation by selectively blocking the COX-2 enzyme, which is primarily responsible for the synthesis of prostaglandins involved in inflammatory responses. By targeting COX-2, ECOXIB 60 MR aims to provide effective anti-inflammatory and analgesic effects while potentially minimizing some of the gastrointestinal side effects associated with non-selective NSAIDs that also inhibit COX-1.

The 'MR' (Modified Release) formulation ensures a sustained therapeutic effect, allowing for once-daily dosing and consistent symptom control throughout the day. This makes it particularly suitable for the long-term management of chronic inflammatory conditions. Its clinical utility lies in providing significant relief from pain and stiffness, thereby improving the quality of life for patients suffering from various musculoskeletal and arthritic conditions, with a favorable safety profile compared to traditional NSAIDs in terms of gastrointestinal tolerability.

Uses

• Treatment of osteoarthritis symptoms
• Relief from rheumatoid arthritis pain
• Management of ankylosing spondylitis
• Alleviation of acute gouty arthritis

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Provides effective pain relief
• Significantly reduces inflammation
• Improves joint mobility and function
• Offers convenient once-daily dosing
• Potentially lower gastrointestinal risk
• Long-lasting therapeutic effect

Side Effects

• Nausea
• Indigestion
• Stomach pain
• Diarrhea
• Headache
• Dizziness
• Fluid retention
• High blood pressure
• Skin rash
• Heartburn
• Flatulence
• Abdominal discomfort

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of gastrointestinal bleeding and liver effects when taken with Etoricoxib.
• Pregnancy - Not recommended, especially during the third trimester, due to potential adverse effects on fetal cardiovascular development. Consult your doctor.
• Breastfeeding - Consult your doctor. Etoricoxib may pass into breast milk, and potential risks to the infant should be carefully considered.
• Liver - Use with caution in patients with mild to moderate liver impairment. Contraindicated in severe liver disease. Regular monitoring of liver function is essential.
• Kidney - Use with caution in patients with kidney conditions. Etoricoxib can impair renal function; close monitoring of kidney parameters is recommended.
• Lung - Caution is advised in patients with asthma, as selective COX-2 inhibitors can sometimes trigger or exacerbate bronchospasm in susceptible individuals.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.